Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Neuromodulation and neural interfaces

Advances in closed-loop deep brain stimulation devices.

Mahboubeh Parastarfeizabadi; Abbas Z Kouzani

Originally published in Journal of neuroengineering and rehabilitation · 2017-08-11

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Background Millions of patients around the world are affected by neurological and psychiatric disorders. Deep brain stimulation (DBS) is a device-based therapy that could have fewer side-effects and higher efficiencies in drug-resistant patients compared to other therapeutic options such as pharmacological approaches. Thus far, several efforts have been made to incorporate a feedback loop into DBS devices to make them operate in a closed-loop manner. Methods This paper presents a comprehensive investigation into the existing research-based and commercial closed-loop DBS devices. It describes a brief history of closed-loop DBS techniques, biomarkers and algorithms used for closing the feedback loop, components of the current research-based and commercial closed-loop DBS devices, and advancements and challenges in this field of research. This review also includes a comparison of the closed-loop DBS devices and provides the future directions of this area of research. Results Although we are in the early stages of the closed-loop DBS approach, there have been fruitful efforts in design and development of closed-loop DBS devices.

Conclusion

Recent advances in the closed-loop DBS systems provide a brighter future for patients in need of DBS treatment. The next generation of DBS devices is expected to be fully and automatically programmable, compatible with biomarker variations, and flexible in stimulation type and pattern, to yield greater benefits and fewer side effects. Since a new technology has to be accessible to all patients over the world, the next closed-loop designs need to be inexpensive to become available even in developing countries.

Editorial reading guide

  • How were patients or cases selected, and what did the authors use as a comparator?
  • Which outcomes, complications and follow-up intervals determine how far the findings apply?